Defining Intestinal Failure
Intestinal failure (IF) is defined as the reduction of functional gut mass below the minimum necessary to absorb sufficient nutrients and fluid to maintain health and growth. The core consequence: the patient cannot sustain themselves through oral or enteral intake alone and requires parenteral nutrition (PN) for survival.
This is distinct from malabsorption, malnutrition, or diarrhea — IF implies dependence on IV nutritional support as a life-sustaining intervention.
Classification
IF is classified by the European Society for Clinical Nutrition and Metabolism (ESPEN) into three types:
- Type 1: Short-term, self-limiting (e.g., post-surgical ileus, acute critical illness). Most common. Resolves with supportive care.
- Type 2: Prolonged acute condition requiring PN for weeks to months (e.g., major abdominal catastrophe — anastomotic breakdown, enterocutaneous fistula, short bowel after emergency resection). Often reversible with specialized multidisciplinary management.
- Type 3: Chronic, stable, not likely to reverse — the patient requires home PN indefinitely. This is the population in whom intestinal transplantation becomes relevant.
Etiology: Short Bowel Syndrome
The most common cause of chronic IF is short bowel syndrome (SBS) — massive small intestinal resection leaving insufficient absorptive surface. In adults, IF generally occurs when <100–150 cm of functional small intestine remains (normal ~600 cm). Common causes of SBS:
- Adults: Mesenteric ischemia (most common adult cause), Crohn's disease with repeated resections, volvulus, trauma, radiation enteritis
- Pediatric: Necrotizing enterocolitis (NEC), gastroschisis, intestinal atresia, volvulus — SBS is the most common indication for intestinal transplant in children
Other etiologies of chronic IF include intestinal dysmotility disorders (e.g., chronic intestinal pseudo-obstruction), mucosal disease (rare, e.g., microvillous inclusion disease), and radiation injury.
Parenteral Nutrition: The Bridge and the Problem
Long-term PN is life-sustaining for patients with chronic IF but carries serious complications:
- Catheter-related bloodstream infections (CRBSI): The leading complication. Recurrent CRBSIs can exhaust venous access sites, eventually making PN delivery impossible — a critical indication trigger for transplant listing.
- Intestinal failure-associated liver disease (IFALD): PN-induced hepatic injury, ranging from hepatic steatosis to cholestasis to end-stage cirrhosis. Severe IFALD is a major indication for combined liver-intestinal transplantation.
- Thrombosis: Central venous thrombosis is common with long-term central lines, further limiting venous access.
- Metabolic complications: Metabolic bone disease, renal oxalate stones, dehydration with renal insufficiency
- Quality of life: PN infusions often require 12–16 hours/night, with significant impact on sleep, social function, and employment
Intestinal Rehabilitation: Before Transplant
Intestinal transplantation is not the first-line approach. An organized intestinal rehabilitation program is essential:
- Dietary optimization: high-complex-carbohydrate, low-fat, low-oxalate diet; oral rehydration solutions
- Medications: loperamide, codeine (reduce motility), proton pump inhibitors (reduce gastric hypersecretion), cholestyramine (bile acid malabsorption)
- GLP-2 analogues (teduglutide / Gattex): FDA-approved for SBS in adults and children. Stimulates intestinal adaptation, promotes mucosal growth, and can reduce or eliminate PN dependence in a significant proportion of patients. A major advance in the field.
- Autologous intestinal reconstruction (STEP procedure, Bianchi procedure): surgical intestinal lengthening procedures that can restore function in selected pediatric patients
Indications for Intestinal Transplantation
Intestinal transplant is reserved for patients with chronic IF who are failing PN — specifically when:
- Loss of venous access: Two or more central venous thromboses (subclavian, jugular) or exhaustion of venous sites
- Recurrent, life-threatening CRBSI: Two or more episodes of systemic sepsis per year, or a single episode of fungemia
- PN-induced liver failure (IFALD): Bilirubin >3 mg/dL, portal hypertension, or established cirrhosis → combined liver-intestinal or multivisceral transplant
- Frequent severe dehydration: Despite optimized oral/IV fluid management
Types of Intestinal Transplant
- Isolated intestinal transplant: Small intestine alone (when liver is healthy)
- Combined liver-intestinal transplant: When IFALD has caused significant liver disease
- Multivisceral transplant: Stomach, duodenum, pancreas, small intestine ± liver — for patients with diffuse motility disorders or prior complex abdominal surgery
Intestinal transplant remains technically challenging with higher rejection rates than other solid organ transplants, due to the large lymphoid tissue burden of the transplanted bowel. Outcomes have improved but 5-year graft survival (~50–60%) lags behind liver and kidney transplantation. Centers with high volume have better outcomes.